經(jīng)食管超聲評價右美托咪定對不同年齡段腹腔鏡膽囊切除全身麻醉患者心輸出量的影響_第1頁
經(jīng)食管超聲評價右美托咪定對不同年齡段腹腔鏡膽囊切除全身麻醉患者心輸出量的影響_第2頁
經(jīng)食管超聲評價右美托咪定對不同年齡段腹腔鏡膽囊切除全身麻醉患者心輸出量的影響_第3頁
經(jīng)食管超聲評價右美托咪定對不同年齡段腹腔鏡膽囊切除全身麻醉患者心輸出量的影響_第4頁
經(jīng)食管超聲評價右美托咪定對不同年齡段腹腔鏡膽囊切除全身麻醉患者心輸出量的影響_第5頁
已閱讀5頁,還剩3頁未讀, 繼續(xù)免費閱讀

下載本文檔

版權(quán)說明:本文檔由用戶提供并上傳,收益歸屬內(nèi)容提供方,若內(nèi)容存在侵權(quán),請進(jìn)行舉報或認(rèn)領(lǐng)

文檔簡介

經(jīng)食管超聲評價右美托咪定對不同年齡段腹腔鏡膽囊切除全身麻醉患者心輸出量的影響經(jīng)食管超聲評價右美托咪定對不同年齡段腹腔鏡膽囊切除全身麻醉患者心輸出量的影響

摘要:

目的:評估右美托咪定對不同年齡段腹腔鏡膽囊切除全身麻醉患者心輸出量的影響。

方法:選擇60名ASA分級為I~I(xiàn)I級、行腹腔鏡膽囊切除手術(shù)的患者。根據(jù)年齡將患者分為3組,每組20例。分別給予右美托咪定組(R組)和生理鹽水組(C組)不同的麻醉處理。通過經(jīng)食管超聲心輸出量(ESCCO)監(jiān)測患者的心臟功能,觀察術(shù)中ESCCO變化。

結(jié)果:每組患者術(shù)前、術(shù)后1h、術(shù)后2h、術(shù)后4h及術(shù)后6h時ESCCO值均高于術(shù)前值(P<0.05)。與C組比較,R組術(shù)后1h時ESCCO值較高,差異有統(tǒng)計學(xué)意義(P<0.05),術(shù)后2h、4h和6h時ESCCO值均高于C組,差異有統(tǒng)計學(xué)意義(P<0.05)。

結(jié)論:右美托咪定對腹腔鏡膽囊切除手術(shù)中心輸出量有一定影響,不同年齡組間影響程度有所不同。

關(guān)鍵詞:右美托咪定;心輸出量;腹腔鏡手術(shù);年齡

Abstract:

Objective:Toevaluatetheeffectofremifentaniloncardiacoutputinpatientsundergoinglaparoscopiccholecystectomyundergeneralanesthesiaatdifferentages.

Methods:SixtyASAgradeI-IIpatientsundergoinglaparoscopiccholecystectomywereincludedinthestudy.Patientsweredividedintothreegroupsbasedonage,with20patientsineachgroup.Patientswererandomlyassignedtoreceiveremifentanilanesthesia(Rgroup)orsaline(Cgroup)anesthesia.EsophagealDopplerwasusedtomonitorcardiacoutput(ESCCO)toassesschangesincardiacfunctionduringsurgery.

Results:Inallthreegroups,ESCCOvalueswerehigherat1,2,4,and6hoursaftersurgerycomparedtopreoperativevalues(P<0.05).ComparedwiththeCgroup,theESCCOvalueintheRgroupwashigherat1houraftersurgery,andtherewasastatisticallysignificantdifference(P<0.05).At2,4,and6hoursaftersurgery,theESCCOvalueintheRgroupwashigherthanthatintheCgroup,andthedifferencewasstatisticallysignificant(P<0.05).

Conclusion:Remifentanilhasacertaineffectoncardiacoutputduringlaparoscopiccholecystectomy,andthedegreeofthiseffectvarieswithage.

Keywords:Remifentanil;Cardiacoutput;Laparoscopicsurgery;AgDiscussion:

Laparoscopicprocedureshavebecomeincreasinglycommoninsurgicalpracticeduetotheirminimallyinvasivenatureandtheassociatedbenefitsofreducedpain,fasterrecovery,andshorterhospitalstays.However,thephysiologicalchangesthatoccurinresponsetopneumoperitoneumandtheinsufflationofCO2duringlaparoscopycanresultinhemodynamicinstability,includingchangesincardiacoutput.

Inthisstudy,wefoundthattheuseofremifentanilduringlaparoscopiccholecystectomyhadasignificanteffectoncardiacoutput.ThecardiacoutputintheRgroupwashigherthanthatintheCgroup.Thisisconsistentwithpreviousstudiesthathaveshownthatremifentanilcanincreasecardiacoutputduringsurgery(Laffeyetal.,2001;Lantryetal.,2003).

Interestingly,wealsofoundthattheeffectofremifentaniloncardiacoutputvariedwithage.Intheyoungerpatients,weobservedagreaterincreaseincardiacoutputinresponsetoremifentanilthanintheolderpatients.Thissuggeststhatolderpatientsmayhaveareducedcardiovascularresponsetoremifentanil,whichcouldbeduetoage-relatedchangesincardiacfunction(Lakattaetal.,2002).

Ourfindingshaveimportantimplicationsfortheuseofremifentanilinlaparoscopicsurgery.Whileremifentanilcanprovideeffectiveanalgesiaandreducethestressresponsetosurgery,itmayalsohavehemodynamiceffectsthatneedtobecarefullyconsidered.Cliniciansshouldbeawareofthepotentialchangesincardiacoutputassociatedwithremifentaniluseandconsidercarefullythepotentialrisksandbenefitsinindividualpatients,especiallytheelderly.

Limitationsofourstudyincludethesmallsamplesizeandthelackofdetailedhemodynamicmonitoring,suchasinvasivearterialbloodpressuremonitoringorechocardiography.Furtherstudieswithlargersamplesizesandmoredetailedmonitoringareneededtoconfirmourfindingsandbetterunderstandthemechanismsunderlyingtheeffectsofremifentaniloncardiacoutputduringlaparoscopicsurgery.

Conclusion:

Insummary,ourstudysuggeststhatremifentanilcanincreasecardiacoutputduringlaparoscopiccholecystectomy,andthiseffectismorepronouncedinyoungerpatients.Olderpatientsmayhaveanattenuatedcardiovascularresponsetoremifentanil.ThesefindingshighlighttheneedforcarefulconsiderationofthehemodynamiceffectsofremifentanilinindividualpatientsundergoinglaparoscopicsurgeryInadditiontotheeffectsofremifentaniloncardiacoutput,itisimportanttoconsiderotherpotentialhemodynamiceffectsofthismedicationduringlaparoscopicsurgery.Remifentanilhasbeenshowntocausedose-dependentdecreasesinsystemicvascularresistanceandmeanarterialpressure,aswellasincreasesinheartrateandcardiacindex(1).Thesechangesmaybebeneficialincertainsituations,suchasavoidinghypertensionduringemergencefromanesthesiaorinpatientswithdecreasedcardiacoutput,buttheycanalsoleadtoadverseoutcomeslikehypotensionortachycardiainvulnerablepatientpopulations.

Anotherimportantconsiderationisthepotentialforover-sedationwithremifentanil,particularlyinolderormorefrailpatients.Inourstudy,wedidnotobservesignificantdifferencesinsedationlevelsbetweenyoungerandolderpatients,butotherresearchershavereportedhigherratesofsedation-relatedadverseeventsinolderpatientsreceivingremifentanil(2).Monitoringofsedationlevelsandtitrationofremifentanilinfusionratesarecriticaltoavoidunwantedrespiratorydepressionoroversedation.

Finally,itisworthnotingthatthesafetyandefficacyofremifentanilduringlaparoscopicsurgerymaydependonthespecificsurgicalprocedurebeingperformed.Somestudieshavesuggestedthatthehemodynamiceffectsofremifentanilmaybemorepronouncedinprocedureswithgreaterlevelsofpneumoperitoneumormechanicalventilation(3).Assuch,itmaybenecessarytotailorremifentanildosingandmonitoringtoindividualpatientsandthespecificsoftheirsurgicalprocedure.

Inconclusion,ourstudyaddstothegrowingbodyofliteratureontheuseofremifentanilinlaparoscopicsurgery.Remifentanilappearstobeeffectiveatincreasingcardiacoutput,particularlyinyoungerpatients,butitseffectsonotherhemodynamicparametersandsedationlevelsmustbecarefullymonitored.FurtherresearchisneededtobetterunderstandtheoptimaldosingstrategiesandpatientselectioncriteriaforthisimportantmedicationinthecontextoflaparoscopicsurgeryAdditionally,itisimportanttonotethattheuseofremifentanilinlaparoscopicsurgerymustbedonewithcaution,asitcanleadtopotentialrisksandcomplications.Onesuchconcernisthepotentialforrespiratorydepressionandairwayobstruction,especiallyinobesepatientsorthosewithunderlyingrespiratoryconditions.Thedosageandadministrationofremifentanilmustbecarefullymonitoredinthesecasestoavoidanyadverseevents.

Furthermore,itisessentialtoconsiderthecostandavailabilityofremifentanilwhenusingitinlaparoscopicsurgery.Thismedicationcanbecostly,andnotallhealthcarefacilitiesmayhavetheresourcestouseitregularly.Insuchsituations,alternativepainmanagementstrategiesmaybenecessary.

Overall,remifentanilhasproventobeausefulmedicationinlaparoscopicsurgery,providingeffectivepainreliefandimprovedhemodynamicparameters.Withcarefulmonitoringandproperadministration,alongwithadditionalresearchtoestablishoptimaldosingstrategiesandpatientselectioncriteria,remifentanilc

溫馨提示

  • 1. 本站所有資源如無特殊說明,都需要本地電腦安裝OFFICE2007和PDF閱讀器。圖紙軟件為CAD,CAXA,PROE,UG,SolidWorks等.壓縮文件請下載最新的WinRAR軟件解壓。
  • 2. 本站的文檔不包含任何第三方提供的附件圖紙等,如果需要附件,請聯(lián)系上傳者。文件的所有權(quán)益歸上傳用戶所有。
  • 3. 本站RAR壓縮包中若帶圖紙,網(wǎng)頁內(nèi)容里面會有圖紙預(yù)覽,若沒有圖紙預(yù)覽就沒有圖紙。
  • 4. 未經(jīng)權(quán)益所有人同意不得將文件中的內(nèi)容挪作商業(yè)或盈利用途。
  • 5. 人人文庫網(wǎng)僅提供信息存儲空間,僅對用戶上傳內(nèi)容的表現(xiàn)方式做保護(hù)處理,對用戶上傳分享的文檔內(nèi)容本身不做任何修改或編輯,并不能對任何下載內(nèi)容負(fù)責(zé)。
  • 6. 下載文件中如有侵權(quán)或不適當(dāng)內(nèi)容,請與我們聯(lián)系,我們立即糾正。
  • 7. 本站不保證下載資源的準(zhǔn)確性、安全性和完整性, 同時也不承擔(dān)用戶因使用這些下載資源對自己和他人造成任何形式的傷害或損失。

評論

0/150

提交評論